Trade GlaxoSmithKline plc (Extended hours) - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.14 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 35.45 |
| Open | 35.63 |
| 1-Year Change | -11.87% |
| Day's Range | 35.63 - 35.79 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 15, 2025 | 35.45 | -0.25 | -0.70% | 35.70 | 36.10 | 35.23 |
| Apr 14, 2025 | 35.05 | 0.34 | 0.98% | 34.71 | 35.40 | 34.57 |
| Apr 11, 2025 | 34.24 | 0.74 | 2.21% | 33.50 | 34.73 | 33.41 |
| Apr 10, 2025 | 33.55 | -0.42 | -1.24% | 33.97 | 34.33 | 32.67 |
| Apr 9, 2025 | 34.23 | 1.26 | 3.82% | 32.97 | 34.79 | 31.96 |
| Apr 8, 2025 | 34.01 | -0.14 | -0.41% | 34.15 | 35.10 | 33.66 |
| Apr 7, 2025 | 34.75 | -0.38 | -1.08% | 35.13 | 35.66 | 34.12 |
| Apr 4, 2025 | 36.22 | -1.95 | -5.11% | 38.17 | 38.41 | 35.98 |
| Apr 3, 2025 | 38.61 | 0.11 | 0.29% | 38.50 | 39.38 | 37.98 |
| Apr 2, 2025 | 37.13 | 0.25 | 0.68% | 36.88 | 37.66 | 36.82 |
| Apr 1, 2025 | 37.77 | -0.85 | -2.20% | 38.62 | 38.93 | 37.60 |
| Mar 31, 2025 | 38.58 | 0.21 | 0.55% | 38.37 | 38.78 | 37.83 |
| Mar 28, 2025 | 38.58 | 0.16 | 0.42% | 38.42 | 38.92 | 38.42 |
| Mar 27, 2025 | 38.34 | 0.49 | 1.29% | 37.85 | 38.61 | 37.80 |
| Mar 26, 2025 | 38.10 | -0.35 | -0.91% | 38.45 | 38.51 | 37.69 |
| Mar 25, 2025 | 38.50 | 0.13 | 0.34% | 38.37 | 39.31 | 38.03 |
| Mar 24, 2025 | 38.50 | -0.86 | -2.18% | 39.36 | 39.49 | 38.36 |
| Mar 21, 2025 | 38.95 | -0.42 | -1.07% | 39.37 | 39.87 | 38.95 |
| Mar 20, 2025 | 39.30 | 0.44 | 1.13% | 38.86 | 39.71 | 38.66 |
| Mar 19, 2025 | 39.50 | -0.03 | -0.08% | 39.53 | 39.73 | 38.91 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com